Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membrane components encompass the diverse lipids, proteins, and carbohydrates that constitute the essential structural and functional barriers of bacteria, fungi, and other microorganisms. In bacteria, these include anionic phospholipids like phosphatidylglycerol and cardiolipin, as well as the unique lipopolysaccharide (LPS) found in the outer membrane of Gram-negative species [1, 4]. Fungal membranes are distinguished by the presence of ergosterol, a vital sterol that maintains membrane fluidity and integrity [7]. These components serve as critical therapeutic targets for numerous antimicrobial classes: polymyxins and daptomycin disrupt bacterial membrane integrity through direct interaction and pore formation, while polyenes like amphotericin B target fungal ergosterol to induce lethal ion leakage [2, 5, 9]. Beyond being drug targets, these components function as pathogen-associated molecular patterns (PAMPs) recognized by host innate immune receptors, such as Toll-like receptors (TLRs), to initiate an immune response [16, 17]. Therapeutic challenges associated with targeting the microbial membrane include potential toxicity to host cells due to structural similarities and the emergence of antimicrobial resistance via membrane remodeling or lipid modification [4, 6, 9].
Drugs targeting these components act by disrupting membrane physical integrity, forming transmembrane pores that lead to ion leakage (e.g., potassium efflux), depolarizing the membrane to arrest metabolic processes, or inhibiting the biosynthesis of essential constituents like ergosterol or LPS [1, 2, 7, 10].
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane components.